CN101805308A - 一类含酪氨酸和异恶唑骨架的化合物、其制备方法和用途 - Google Patents
一类含酪氨酸和异恶唑骨架的化合物、其制备方法和用途 Download PDFInfo
- Publication number
- CN101805308A CN101805308A CN200910067852A CN200910067852A CN101805308A CN 101805308 A CN101805308 A CN 101805308A CN 200910067852 A CN200910067852 A CN 200910067852A CN 200910067852 A CN200910067852 A CN 200910067852A CN 101805308 A CN101805308 A CN 101805308A
- Authority
- CN
- China
- Prior art keywords
- phenyl
- compound
- isoxzzole
- dimethylamino
- oxygen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
化合物编号 | 化合物名称 |
I-1 | (S)-2-二甲氨基-3-{{4-[(3-苯基异恶唑-5-基)甲基]氧}苯基}丙酸 |
I-2 | (S)-3-{{4-{[(2-氯苯基)异恶唑-5-基]乙基}氧}苯基}-2-二甲氨基丙酸 |
I-3 | (S)-2-二甲氨基-3-{{4-{[(4-甲氧基苯基)异恶唑-5-基]乙基}氧}苯基}丙酸 |
I-4 | (S)-2-二甲氨基-3-{{4-{[(3-硝基苯基)异恶唑-5-基]乙基}氧}苯基}丙酸 |
I-5 | (S)-3-{{4-{[(2-氰基苯基)异恶唑-5-基]乙基}氧}苯基}-2-二甲氨基丙酸 |
I-6 | (S)-2-二甲氨基-3-{{4-{[(2-甲基苯基)异恶唑-5-基]丙基}氧}苯基}丙酸 |
化合物编号 | 化合物名称 |
I-7 | (S)-2-二甲氨基-3-{{4-{[(3-二甲氨基苯基)异恶唑-5-基]丙基}氧}苯基}丙酸 |
I-8 | (S)-2-二甲氨基-3-{{4-{[(2-甲基-3-硝基苯基)异恶唑-5-基]乙基}氧}苯基}丙酸 |
I-9 | (S)-3-{{4-{[(2-氯-3-氰基-4-甲氧基苯基)异恶唑-5-基]乙基}氧}苯基}-2-二甲氨基丙酸 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100678521A CN101805308B (zh) | 2009-02-13 | 2009-02-13 | 一类含酪氨酸和异噁唑骨架的化合物、其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100678521A CN101805308B (zh) | 2009-02-13 | 2009-02-13 | 一类含酪氨酸和异噁唑骨架的化合物、其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101805308A true CN101805308A (zh) | 2010-08-18 |
CN101805308B CN101805308B (zh) | 2011-10-19 |
Family
ID=42607277
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100678521A Expired - Fee Related CN101805308B (zh) | 2009-02-13 | 2009-02-13 | 一类含酪氨酸和异噁唑骨架的化合物、其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101805308B (zh) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100436430C (zh) * | 2004-05-24 | 2008-11-26 | 北京摩力克科技有限公司 | 作为hPPARα和hPPARγ激动剂的烷酰基取代的酪氨酸衍生物 |
-
2009
- 2009-02-13 CN CN2009100678521A patent/CN101805308B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN101805308B (zh) | 2011-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI765157B (zh) | 含葡萄糖激酶啟動劑和α-葡萄糖苷酶抑制劑的藥物組合及其製備方法和用途 | |
KR101699912B1 (ko) | 1종 이상의 푸마르산 에스테르를 침식 매트릭스에 함유하는 제제 | |
EP2116242B1 (en) | New pharmaceutical composition | |
US20090191265A1 (en) | Capsule Formulation of Pirfenidone and Pharmaceutically Acceptable Excipients | |
KR20010040484A (ko) | 셀레코시브 조성물 | |
BR112012028857B1 (pt) | Composições farmacêuticas administráveis por via oral que compreendem derivados de 1- (beta-d glucopiranosil)-2-tienil-metilbenzeno como inibidores de sglt | |
WO2008122190A1 (fr) | Composition comprenant de la l-carnitine ou ses dérivés et son utilisation | |
US20060240101A1 (en) | Orally disintegrating pharmaceutical tablet formulations of olanzapine | |
KR20210125994A (ko) | 비정질 스파르센탄 조성물 | |
CN111635309A (zh) | 一种新型解热镇痛药物及其制备方法和用途 | |
CN111635315A (zh) | 一种解热镇痛药物及其制备方法和应用 | |
WO1999025338A1 (en) | Pharmaceutical composition containing zafirlukast | |
CN101805308B (zh) | 一类含酪氨酸和异噁唑骨架的化合物、其制备方法和用途 | |
CN103570657A (zh) | 一类含偕二甲基的苯基c-葡萄糖苷衍生物、其制备方法和用途 | |
CN101715448A (zh) | 一种咪唑-5-羧酸衍生物的治疗用途 | |
CN113943284B (zh) | 盐酸吡格列酮没食子酸共晶及制备方法和其组合物与用途 | |
CN101492427A (zh) | 5-溴代噻唑衍生物、其制备方法和用途 | |
WO2022051316A1 (en) | Fixed dose combinations of chs-131 and a sglt-2 inhibitor | |
CN100455288C (zh) | 一种盐酸雷诺嗪制剂配方 | |
CN103467405B (zh) | 一类四氮唑羧酸类化合物、其制备方法和用途 | |
CN112933070A (zh) | 一种激酶抑制剂及其在制备防治TrkA/B/C激酶异常活化导致疾病药物的用途 | |
CN101805336B (zh) | 一类含色氨酸和异恶唑骨架的化合物、其制备方法和用途 | |
CN103626722A (zh) | 一氧化氮供体型降血糖化合物、其制备方法和用途 | |
CN116139127B (zh) | 一种酰胺类化合物在制备预防或治疗代谢综合征药物中的用途 | |
CN101684103B (zh) | 1,2,4-三唑结构的化合物、其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: 300193 Anshan West Road, Nankai District, Nankai District, Tianjin Patentee after: TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH CO., LTD. Address before: 300193 Anshan West Road, Nankai District, Nankai District, Tianjin Patentee before: Tianjin Institute of Pharmaceutical Research |
|
CP01 | Change in the name or title of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190220 Address after: 300301 No. 308 Huiren Road, Binhai Science Park, Tianjin Binhai High-tech Zone Patentee after: NEW DRUGS EVALUATE CO., LTD., TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH Address before: 300193 Anshan West Road, Nankai District, Nankai District, Tianjin Patentee before: TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH CO., LTD. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111019 Termination date: 20200213 |
|
CF01 | Termination of patent right due to non-payment of annual fee |